Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the Modified-parallel, Placebo-controlled, Double-blind, Phase 3 Consistency CENTURION Study

被引：0
|
作者：
Reuter, U. [1 ]
Lombard, L. [2 ]
Krege, J. [2 ]
Valderas, E. Gomez [2 ]
Krikke-Workel, J. [2 ]
Agnello, G. Dell [2 ]
Dowsett, S. [2 ]
Buse, D. C. [3 ]
机构：
[1] Charite, Dept Neurol, Berlin, Germany
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Albert Einstein Coll Med, New York, NY USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0387
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the Modified-parallel, Placebo-controlled, Double-blind, Phase 3 Consistency CENTURION Study
    Reuter, U.
    Lombard, L.
    Krege, J.
    Valderas, E. Gomez
    Krikke-Workel, J.
    Agnello, G. Dell
    Dowsett, S.
    Buse, D. C.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 203 - 203
  • [2] Lasmiditan is effective in the acute treatment of migraine in patients with insufficient response to triptans: Findings from the CENTURION study
    Lombard, L. A.
    Reuter, U.
    Krege, J. H.
    Krikke-Workel, J.
    Wilhelm, S.
    Kovacik, A. J.
    Lin, Q.
    Dowsett, S.
    Buse, D. C.
    [J]. HEADACHE, 2021, 61 : 156 - 156
  • [3] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the CENTURION Study
    Reuter, Uwe
    Lombard, Louise
    Krege, John
    Krikke-Workel, Judith
    Wilhelm, Stefan
    Kovacik, Amy J.
    Lin, Qun
    Dowsett, Sherie
    Buse, Dawn
    [J]. NEUROLOGY, 2021, 96 (15)
  • [4] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    [J]. BRAIN, 2019, 142 : 1894 - 1904
  • [5] Safety Findings from CENTURION, a Phase 3 Consistency Study of Lasmiditan for the Acute Treatment of Migraine
    Tassorelli, C.
    Bragg, S.
    Krege, J.
    Doty, E. G.
    Ardayfio, P. A.
    Ruff, D.
    Dowsett, S.
    Schwedt, T. J.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 79 - 79
  • [6] Safety Findings from CENTURION, a Phase 3 Consistency Study of Lasmiditan for the Acute Treatment of Migraine
    Tassorelli, C.
    Bragg, S.
    Krege, J.
    Doty, E. G.
    Ardayfio, P. A.
    Ruff, D.
    Dowsett, S.
    Schwedt, T. J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 52 - 52
  • [7] Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
    Tassorelli, C.
    Bragg, S.
    Krege, J. H.
    Doty, E. G.
    Ardayfio, P. A.
    Ruff, D.
    Dowsett, S. A.
    Schwedt, T.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [8] Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
    C Tassorelli
    S Bragg
    JH Krege
    EG Doty
    PA Ardayfio
    D Ruff
    SA Dowsett
    T Schwedt
    [J]. The Journal of Headache and Pain, 2021, 22
  • [9] Safety Findings from CENTURION, a Phase 3 Consistency Study of Lasmiditan for the Acute Treatment of Migraine
    Tassorelli, C.
    Bragg, S.
    Krege, J.
    Doty, E.
    Ardayfio, P.
    Ruff, D.
    Dowsett, S.
    Schwedt, T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 269 - 269
  • [10] Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study
    Reuter, Uwe
    Krege, John H.
    Lombard, Louise
    Valderas, Elisa Gomez
    Krikke-Workel, Judith
    Dell-Agnello, Grazia
    Dowsett, Sherie A.
    Buse, Dawn C.
    [J]. CEPHALALGIA, 2022, 42 (01) : 20 - 30
12345